Lanean...
Tumor-Targeting of EGFR Inhibitors by Hypoxia-Mediated Activation()
The development of receptor tyrosine-kinase inhibitors (TKIs) was a major step forward in cancer treatment. However, the therapy with TKIs is limited by strong side effects and drug resistance. The aim of this study was the design of novel epidermal growth factor receptor (EGFR) inhibitors that are...
Gorde:
| Argitaratua izan da: | Angew Chem Int Ed Engl |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4336855/ https://ncbi.nlm.nih.gov/pubmed/25079700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.201403936 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|